Live Research Database
Psoriasis
Hub: Houston, TX
Connecting patients in Houston with breakthrough clinical trials, specialized care, and study-related compensation.
+4k
Join 4,200+ participants tracking trials in Texas
Available Psoriasis Opportunities
12 RecruitingNCT06857942(Verify)
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
RECRUITING
Psoriasis
NCT07486960(Verify)
Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
RECRUITING
Psoriasis
NCT03816345(Verify)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RECRUITING
Psoriasis
NCT04751396(Verify)
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
RECRUITING
Psoriasis
NCT07116967(Verify)
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
RECRUITING
Psoriasis
NCT07290569(Verify)
Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis
RECRUITING
Psoriasis
NCT06864026(Verify)
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
RECRUITING
Psoriasis
NCT02418442(Verify)
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
RECRUITING
Psoriasis
NCT06641089(Verify)
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
RECRUITING
Psoriasis
NCT06671496(Verify)
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
RECRUITING
Psoriasis
NCT06671483(Verify)
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
RECRUITING
Psoriasis
NCT06865105(Verify)
Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
RECRUITING
Psoriasis
Patient Safeguards
IRB Oversight
Ethics Committee Approved
HIPAA Compliant
Full Data Privacy
NIH Standards
Global Quality Benchmarks
"Advancing Psoriasis research in Houston through safe, transparent, and patient-first clinical trials."
Research Hubs in Houston
Explore other local breakthroughs
Psoriasis Hubs in TX
Regional Network of Excellence
ClinicalTrials.govFDA REGISTEREDIRB OVERSIGHTHIPAA COMPLIANT